-
Company Profile
Bausch Health Companies Inc – Company Profile
Bausch Health Companies Inc (Bausch Health), formerly Valeant Pharmaceuticals International Inc, is engaged in the manufacturing, development, and marketing of a range of medical devices, over-the-counter products (OTC), and pharmaceutical products. Bausch Health offers products for therapy areas related to dermatology, gastroenterology, eye health, neurology, aesthetic devices, dentistry, and consumer health. It offers various generic and branded generic products. Bausch Health has administrative, research and laboratory, marketing, distribution, and warehousing facilities worldwide. The company offers products directly or indirectly in...
Add to Basket -
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in December 2017. The industry reported 375 deals worth USD21 billion in December 2017, compared to 403 deals worth USD27.5 billion in November 2017. The oncology therapeutics market remained at the top in deal activity in December 2017 with 124 deals. In second place, central nervous system therapeutics market reported 77 deals. Licensing agreements in pharmaceutical and healthcare industry registered an increase in upfront...
-
Product Insights
Mycoses Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Mycoses Global Clinical Trials Review, H1, 2018" provides an overview of Mycoses clinical trials scenario. This report provides top line data relating to the clinical trials on Mycoses. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for March 2018 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2018. The report portrays detailed comparative data on the number of deals and their value in the last...
-
Track & Monitor
PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2018 Edition
This report is the 8th edition of our long running analysis of the CMO Industry, using NDA approvals as the primary indicator of performance. CMO Scorecard is critical for benchmarking the performance of the CMO industry and the relative performance of major CMOs.
-
Product Insights
Ocular Hypertension Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Ocular Hypertension Global Clinical Trials Review, H1, 2018" provides an overview of Ocular Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Hypertension. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Ocular Inflammation Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Ocular Inflammation Global Clinical Trials Review, H1, 2018" provides an overview of Ocular Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Inflammation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Neovascular Glaucoma Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neovascular Glaucoma Global Clinical Trials Review, H1, 2018" provides an overview of Neovascular Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Neovascular Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Non Malignant pain Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Non Malignant pain Global Clinical Trials Review, H1, 2018" provides an overview of Non Malignant pain clinical trials scenario. This report provides top line data relating to the clinical trials on Non Malignant pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...